Patent Term Application for FORZINITY (elamipretide), Patent No. 7,576,061

Documents

Comments

Key Dates

Comment Period OpensDec 18, 2025

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Apr 20, 2026	--	--

CDER

Foley and Lardner LLP

Cornell Research Foundation Inc

Institut de Recherches Cliniques de Montreal

Patent Term Application

FORZINITY elamipretide

Patent No 7 576 061

OPEN